These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18330697

  • 21. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):357-64. PubMed ID: 18676091
    [Abstract] [Full Text] [Related]

  • 22. Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
    Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M, Austrian Breast and Colorectal Cancer Study Group.
    Clin Cancer Res; 2008 Mar 15; 14(6):1767-74. PubMed ID: 18347178
    [Abstract] [Full Text] [Related]

  • 23. CXCR4 membrane expression in node-negative breast cancer.
    Blot E, Laberge-Le Couteulx S, Jamali H, Cornic M, Guillemet C, Duval C, Hellot MF, Pille JY, Picquenot JM, Veyret C.
    Breast J; 2008 Mar 15; 14(3):268-74. PubMed ID: 18373506
    [Abstract] [Full Text] [Related]

  • 24. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E.
    Am J Clin Oncol; 2009 Jun 15; 32(3):245-52. PubMed ID: 19451802
    [Abstract] [Full Text] [Related]

  • 25. Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostaining.
    Potemski P, Pluciennik E, Bednarek AK, Kusinska R, Jesionek-Kupnicka D, Pasz-Walczak G, Watala C, Kordek R.
    Jpn J Clin Oncol; 2006 Mar 15; 36(3):142-9. PubMed ID: 16520356
    [Abstract] [Full Text] [Related]

  • 26. [Clinicopathological characteristics and prognosis of patients with breast cancer over 65 years of age].
    Gao JD, Zhang BN, Wang X, Wang J, Bi XF.
    Zhonghua Yi Xue Za Zhi; 2009 Jan 13; 89(2):83-6. PubMed ID: 19489267
    [Abstract] [Full Text] [Related]

  • 27. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.
    J Natl Cancer Inst; 2008 Oct 01; 100(19):1380-8. PubMed ID: 18812550
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008 Oct 01; 55(3):229-38. PubMed ID: 18348656
    [Abstract] [Full Text] [Related]

  • 29. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis.
    Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, Hopper JL, Martin TJ.
    Cancer Res; 2006 Feb 15; 66(4):2250-6. PubMed ID: 16489028
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [A study on the relationship between breast cancer molecular classification and prognosis].
    Chen XS, Ma CD, Chen CM.
    Zhonghua Wai Ke Za Zhi; 2008 Sep 15; 46(18):1400-3. PubMed ID: 19094512
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Can sentinel node biopsy be avoided in some elderly breast cancer patients?
    Chagpar AB, McMasters KM, Edwards MJ, North American Fareston Tamoxifen Adjuvant Trial.
    Ann Surg; 2009 Mar 15; 249(3):455-60. PubMed ID: 19247034
    [Abstract] [Full Text] [Related]

  • 37. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 15; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

  • 38. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
    Lukens JN, Vapiwala N, Hwang WT, Solin LJ.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1475-81. PubMed ID: 19004570
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
    Breast Cancer Res; 2008 Apr 01; 10(5):R88. PubMed ID: 18928543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.